Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Saved in:
| Main Authors: | , , |
|---|---|
| Other Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2015
|
| In: |
The lancet
Year: 2014, Volume: 385, Issue: 9976, Pages: 1418-1427 |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(14)61469-0 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0140-6736(14)61469-0 |
| Author Notes: | Karolin Behringer, Helen Goergen, Felicitas Hitz, Josée M Zijlstra, Richard Greil, Jana Markova, Stephanie Sasse, Michael Fuchs, Max S Topp, Martin Soekler, Stephan Mathas, Julia Meissner, Martin Wilhelm, Peter Koch, Hans-Walter Lindemann, Enrico Schalk, Robert Semrau, Jan Kriz, Tom Vieler, Martin Bentz, Elisabeth Lange, Rolf Mahlberg, Andre Hassler, Martin Vogelhuber, Dennis Hahn, Jörg Mezger, Stefan W Krause, Nicole Skoetz, Boris Böll, Bastian von Tresckow, Volker Diehl, Michael Hallek, Peter Borchmann, Harald Stein, Hans Eich, Andreas Engert |
| Item Description: | Online 22 December 2014 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(14)61469-0 |